Belgian national action plan for fibrotic interstitial lung disease
Fibrotic interstitial lung diseases (ILD) are a diverse group of serious, often progressive conditions that can cause irreversible lung damage, severe breathlessness, fatigue, loss of independence and premature mortality. Although Belgium has strong clinical expertise, the patient journey remains too dependent on where a person enters the system, how quickly disease is recognised and whether multidisciplinary expertise and supportive care are available. This report presents a national action plan to improve care for people living with fibrotic interstitial lung disease (ILD) in Belgium. Developed through a multi-stakeholder process involving clinicians, patient representatives, policymakers and healthcare experts, it combines scientific evidence with practical policy recommendations. The report identifies key challenges in the current care pathway and proposes four priorities to accelerate diagnosis, improve access to multidisciplinary care, strengthen funding and expertise, and build a data-driven ecosystem. Its aim is to support coordinated action that delivers better outcomes for patients while creating a more sustainable healthcare system.








